Dong Hoon Shin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Dong Hoon Shin has a total of 107 co-authors. Here are the top co-authors by number of shared publications:
Jong Soo Choi
Department of Dermatology, Yeungnam University College of Medicine, Daegu, Korea
13 shared publications- Young Kyung Bae
Department of Pathology, Yeungnam University College of Medicine, Daegu, Korea
10 shared publications - Jong Soo Choi
Department of Dermatology, College of Medicine, Yeungnam University, Daegu, Korea
9 shared publications - Hye Ri Kim
Department of Dermatology, Yeungnam University College of Medicine, Daegu, Korea
6 shared publications - Joon-Goon Kim
Department of Dermatology, Yeungnam University College of Medicine, Daegu, Korea
6 shared publications - Hyeong Mok Kwon
Department of Dermatology, Yeungnam University College of Medicine, Daegu, Korea
5 shared publications
Latest Publications
- 22 January 2026
- Published by Wiley in International Journal of Dermatology
- Vol. 65 (5) , 1090-1091
Giant Palmar Merkel Cell Carcinoma With Prolonged Stability and Abrupt Progression
- 22 January 2026
- Published by Wiley in International Journal of Dermatology
- Vol. 65 (5) , 1090-1091
Giant Palmar Merkel Cell Carcinoma With Prolonged Stability and Abrupt Progression
- Open Access
- 1 January 2026
- Published by XMLink in Annals of Dermatology
- Vol. 38
GATA3 Expression in Eccrine Poroid Neoplasms: Enrichment in a Subset of Porocarcinoma In Situ
Kim MG, et al. Ann Dermatol. 2026 ;38:e74. https://doi.org/10.5021/ad.26.098
- 1 January 2026
- Published by XMLink in Annals of Dermatology
- Vol. 38
Open AccessGATA3 Expression in Eccrine Poroid Neoplasms: Enrichment in a Subset of Porocarcinoma In Situ
Kim MG, et al. Ann Dermatol. 2026 ;38:e74. https://doi.org/10.5021/ad.26.098
- Open Access
- 31 December 2025
- Published by Korean Society for Medical Mycology in Journal of Mycology and Infection
- Vol. 4 (30)
First Molecular Confirmation of Trichophyton indotineae in South Korea: A Case Report
Trichophyton indotineae is an emerging terbinafine-resistant dermatophyte within the T. mentagrophytes / T. interdigitale complex. Herein, we describe the first two confirmed Korean cases of T. indotineae infection. Both patients had chronic and extensive dermatophytosis involving the trunk, buttocks, thighs, and groin in case 1 and confined to the right lower leg and ankle in case 2. In both cases, the eruption failed to respond to terbinafine or itraconazole and was aggravated by intermittent corticosteroid use. Cultures produced white cottony colonies with grape-like microconidia and negative urease reactions. Internal transcribed spacer (ITS) region sequencing identified T. indotineae, and analysis of the squalene epoxidase (SQLE) gene showed L393F mutation, which was associated with terbinafine resistance. Antifungal susceptibility testing revealed terbinafine resistance but susceptibility to itraconazole. After withdrawal of corticosteroids and maintenance of continuous itraconazole therapy, case 1 showed near-complete clinical remission with minimal residual scaling, whereas case 2 achieved complete clinical and mycological remission. These findings suggest possible local transmission and emphasize the importance of molecular confirmation and antifungal stewardship in Korea.
- 31 December 2025
- Published by Korean Society for Medical Mycology in Journal of Mycology and Infection
- Vol. 4 (30)
Open AccessFirst Molecular Confirmation of Trichophyton indotineae in South Korea: A Case Report
Trichophyton indotineae is an emerging terbinafine-resistant dermatophyte within the T. mentagrophytes / T. interdigitale complex. Herein, we describe the first two confirmed Korean cases of T. indotineae infection. Both patients had chronic and extensive dermatophytosis involving the trunk, buttocks, thighs, and groin in case 1 and confined to the right lower leg and ankle in case 2. In both cases, the eruption failed to respond to terbinafine or itraconazole and was aggravated by intermittent corticosteroid use. Cultures produced white cottony colonies with grape-like microconidia and negative urease reactions. Internal transcribed spacer (ITS) region sequencing identified T. indotineae, and analysis of the squalene epoxidase (SQLE) gene showed L393F mutation, which was associated with terbinafine resistance. Antifungal susceptibility testing revealed terbinafine resistance but susceptibility to itraconazole. After withdrawal of corticosteroids and maintenance of continuous itraconazole therapy, case 1 showed near-complete clinical remission with minimal residual scaling, whereas case 2 achieved complete clinical and mycological remission. These findings suggest possible local transmission and emphasize the importance of molecular confirmation and antifungal stewardship in Korea.
- Open Access
A Case of Pediatric Subcutaneous Panniculitis-like T-Cell Lymphoma Successfully Treated with Immunosuppressive Therapy
Introduction: Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a very rare subtype of cutaneous T-cell lymphoma. It is characterized by the neoplastic infiltration of subcutaneous adipose tissue. Its clinical presentation, including subcutaneous nodules, fever, and systemic symptoms, often mimics inflammatory panniculitis, making diagnosis difficult. Case Presentation: This case report describes a 14-year-old female presenting with fever, limb pain, swelling, and subcutaneous nodules, who was ultimately diagnosed with SPTCL via punch biopsy and BIOMED-2 clonality assays, confirming positive T-cell receptor-γ chain gene rearrangement. Positron emission tomography–computed tomography revealed diffuse subcutaneous involvement across multiple body regions. Methylprednisolone and cyclosporine A treatment rapidly resolved her symptoms, with laboratory parameters, including ferritin and inflammatory markers, showing significant improvement. Next-generation sequencing identified a heterozygous C9 gene mutation (c.346C>T, p.Arg116Ter), adding a novel genetic dimension to the case. Following a tapered discontinuation of immunosuppressive therapy, the patient achieved sustained remission without relapse for over 1 year. Conclusions: We report a case of adolescent SPTCL treated with immunosuppressive therapy and suggest that immunosuppressive therapy should be considered before chemotherapy in pediatric patients with SPTCL but without HLH.
Open AccessA Case of Pediatric Subcutaneous Panniculitis-like T-Cell Lymphoma Successfully Treated with Immunosuppressive Therapy
Introduction: Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a very rare subtype of cutaneous T-cell lymphoma. It is characterized by the neoplastic infiltration of subcutaneous adipose tissue. Its clinical presentation, including subcutaneous nodules, fever, and systemic symptoms, often mimics inflammatory panniculitis, making diagnosis difficult. Case Presentation: This case report describes a 14-year-old female presenting with fever, limb pain, swelling, and subcutaneous nodules, who was ultimately diagnosed with SPTCL via punch biopsy and BIOMED-2 clonality assays, confirming positive T-cell receptor-γ chain gene rearrangement. Positron emission tomography–computed tomography revealed diffuse subcutaneous involvement across multiple body regions. Methylprednisolone and cyclosporine A treatment rapidly resolved her symptoms, with laboratory parameters, including ferritin and inflammatory markers, showing significant improvement. Next-generation sequencing identified a heterozygous C9 gene mutation (c.346C>T, p.Arg116Ter), adding a novel genetic dimension to the case. Following a tapered discontinuation of immunosuppressive therapy, the patient achieved sustained remission without relapse for over 1 year. Conclusions: We report a case of adolescent SPTCL treated with immunosuppressive therapy and suggest that immunosuppressive therapy should be considered before chemotherapy in pediatric patients with SPTCL but without HLH.
- Open Access
- 1 January 2025
- Published by XMLink in Annals of Dermatology
- Vol. 37 (2) , 75-85
Primary Cutaneous CD30+ Lymphoproliferative Disorders in South Korea: A Nationwide, Multi-Center, Retrospective, Clinical, and Prognostic Study
Lee WJ, et al. Ann Dermatol. 2024 Dec;37:e1. https://doi.org/10.5021/ad.24.120
- 1 January 2025
- Published by XMLink in Annals of Dermatology
- Vol. 37 (2) , 75-85
Open AccessPrimary Cutaneous CD30+ Lymphoproliferative Disorders in South Korea: A Nationwide, Multi-Center, Retrospective, Clinical, and Prognostic Study
Lee WJ, et al. Ann Dermatol. 2024 Dec;37:e1. https://doi.org/10.5021/ad.24.120
- Open Access
- 1 January 2023
- Published by XMLink in Annals of Dermatology
- Vol. 35 (Suppl 2) , S272-S274
Methotrexate-Induced Accelerated Nodulosis in a Patient with Systemic Lupus Erythematosus
Methotrexate (MTX)-induced accelerated nodulosis (MIAN) reportedly occurs in patients with rheumatic arthritis receiving MTX therapy. However, it has also been reported in patients with other autoinflammatory conditions, such as systemic lupus erythematosus (SLE). A 38-year-old woman diagnosed with SLE presented with multiple movable, firm, fleshcolored nodules on both hands that had developed 3 years ago. She was taking oral medications, specifically hydroxychloroquine, azathioprine, and MTX. Histopathological examination revealed palisaded granulomatous inflammation, surrounded by histiocytes and lymphocytes, along the dermis to the subcutaneous fat layer. Fibrinoid degeneration was observed at the center of the granulomatous inflammation, and dermal mucin deposition was not observed. The patient was diagnosed with MIAN, and therefore discontinuation of MTX was recommended. Subsequently, the lesions almost completely disappeared with no signs of recurrence. MIAN exhibits clinicopathological features similar to those of rheumatoid nodules; therefore, it can be easily misdiagnosed. Herein, we report a case of MIAN in a patient with SLE to contribute to the accurate diagnosis and appropriate management.
- 1 January 2023
- Published by XMLink in Annals of Dermatology
- Vol. 35 (Suppl 2) , S272-S274
Open AccessMethotrexate-Induced Accelerated Nodulosis in a Patient with Systemic Lupus Erythematosus
Methotrexate (MTX)-induced accelerated nodulosis (MIAN) reportedly occurs in patients with rheumatic arthritis receiving MTX therapy. However, it has also been reported in patients with other autoinflammatory conditions, such as systemic lupus erythematosus (SLE). A 38-year-old woman diagnosed with SLE presented with multiple movable, firm, fleshcolored nodules on both hands that had developed 3 years ago. She was taking oral medications, specifically hydroxychloroquine, azathioprine, and MTX. Histopathological examination revealed palisaded granulomatous inflammation, surrounded by histiocytes and lymphocytes, along the dermis to the subcutaneous fat layer. Fibrinoid degeneration was observed at the center of the granulomatous inflammation, and dermal mucin deposition was not observed. The patient was diagnosed with MIAN, and therefore discontinuation of MTX was recommended. Subsequently, the lesions almost completely disappeared with no signs of recurrence. MIAN exhibits clinicopathological features similar to those of rheumatoid nodules; therefore, it can be easily misdiagnosed. Herein, we report a case of MIAN in a patient with SLE to contribute to the accurate diagnosis and appropriate management.
- Open Access
- 1 January 2023
- Published by XMLink in Annals of Dermatology
- Vol. 35 (Suppl 1) , S25-S29
Superficial CD34-Positive Fibroblastic Tumor: Two Case Reports
Yim JE, et al. Ann Dermatol. 2023 May;35:e36. https://doi.org/10.5021/ad.20.328
- 1 January 2023
- Published by XMLink in Annals of Dermatology
- Vol. 35 (Suppl 1) , S25-S29
Open AccessSuperficial CD34-Positive Fibroblastic Tumor: Two Case Reports
Yim JE, et al. Ann Dermatol. 2023 May;35:e36. https://doi.org/10.5021/ad.20.328
- Open Access
- 1 January 2023
- Published by XMLink in Annals of Dermatology
- Vol. 35 (Suppl 1) , S10-S13
Intradermal Low-Fat Spindle Cell Lipoma: A Case Report
Kwon HM, et al. Ann Dermatol. 2023 May;35:e33. https://doi.org/10.5021/ad.21.051
- 1 January 2023
- Published by XMLink in Annals of Dermatology
- Vol. 35 (Suppl 1) , S10-S13
Open AccessIntradermal Low-Fat Spindle Cell Lipoma: A Case Report
Kwon HM, et al. Ann Dermatol. 2023 May;35:e33. https://doi.org/10.5021/ad.21.051
- Open Access
- 15 July 2021
- Published by The Korean Society of Pathologists and The Korean Society for Cytopathology in Journal of Pathology and Translational Medicine
- Vol. 55 (4) , 289-297
Clinicopathologic features of cutaneous metastases from internal malignancies
Background: Cutaneous metastasis (CM) is the spread of cancer cells from a primary site to the skin and is rarely the first sign of silent cancer. We investigated the clinicopathological characteristics of CM from internal malignancies in Korean patients treated at our institution over 20 years. Methods: The clinicopathological findings of 112 patients (62 females, 50 males) with CM diagnosed at Yeungnam University Hospital between 2000 and 2020 were retrospectively reviewed. Results: Mean patient age was 58.6 years (range, 26 to 87 years), and the most common primary cancer site was breast (74.2%) in women and lung (36.0%) in men. Ninety-six patients (85.7%) presented with CM after primary tumor diagnosis. CM from the lung or biliary tract usually occurred within 2 years of primary tumor diagnosis, whereas metastases from the breast and kidney occurred several years later. The chest, abdomen, and scalp were common sites of CM. Breast cancer usually metastasized to chest skin, while gastrointestinal tract cancers commonly metastasized to the abdomen. The scalp was a common location for CM from various tumors. The most common dermatologic presentations were nodules and masses. Immunohistochemical studies helped identify underlying malignancies when primary tumors were unknown.Conclusions: The relative frequency of CM parallels the overall incidence of primary malignant tumors, and CMs usually occur at anatomic sites close to the primary tumor. CM can be diagnosed based on clinical, radiological, and histological features; however, immunohistochemical study is required in some cases.
- 15 July 2021
- Published by The Korean Society of Pathologists and The Korean Society for Cytopathology in Journal of Pathology and Translational Medicine
- Vol. 55 (4) , 289-297
Open AccessClinicopathologic features of cutaneous metastases from internal malignancies
Background: Cutaneous metastasis (CM) is the spread of cancer cells from a primary site to the skin and is rarely the first sign of silent cancer. We investigated the clinicopathological characteristics of CM from internal malignancies in Korean patients treated at our institution over 20 years. Methods: The clinicopathological findings of 112 patients (62 females, 50 males) with CM diagnosed at Yeungnam University Hospital between 2000 and 2020 were retrospectively reviewed. Results: Mean patient age was 58.6 years (range, 26 to 87 years), and the most common primary cancer site was breast (74.2%) in women and lung (36.0%) in men. Ninety-six patients (85.7%) presented with CM after primary tumor diagnosis. CM from the lung or biliary tract usually occurred within 2 years of primary tumor diagnosis, whereas metastases from the breast and kidney occurred several years later. The chest, abdomen, and scalp were common sites of CM. Breast cancer usually metastasized to chest skin, while gastrointestinal tract cancers commonly metastasized to the abdomen. The scalp was a common location for CM from various tumors. The most common dermatologic presentations were nodules and masses. Immunohistochemical studies helped identify underlying malignancies when primary tumors were unknown.Conclusions: The relative frequency of CM parallels the overall incidence of primary malignant tumors, and CMs usually occur at anatomic sites close to the primary tumor. CM can be diagnosed based on clinical, radiological, and histological features; however, immunohistochemical study is required in some cases.
- Open Access
- 1 January 2021
- Published by Korean Dermatological Association and The Korean Society for Investigative Dermatology in Annals of Dermatology
- Vol. 33 (3) , 237-244
Participants' Satisfaction with the Atopic Dermatitis Education Program: Assessing the Impact of Each Content Using Structural Equation Modeling
Ryoo JH, et al. Ann Dermatol. 2021 Jun;33(3):237-244. https://doi.org/10.5021/ad.2021.33.3.237
- 1 January 2021
- Published by Korean Dermatological Association and The Korean Society for Investigative Dermatology in Annals of Dermatology
- Vol. 33 (3) , 237-244
Open AccessParticipants' Satisfaction with the Atopic Dermatitis Education Program: Assessing the Impact of Each Content Using Structural Equation Modeling
Ryoo JH, et al. Ann Dermatol. 2021 Jun;33(3):237-244. https://doi.org/10.5021/ad.2021.33.3.237